Astrana Health, INC DEF 14A proxy statements
Proxy statements, covering the matters put to shareholders at the annual meeting — board elections, auditor ratification and executive pay.
NASDAQ
Astrana Health, Inc. has issued its 2026 proxy statement detailing the upcoming annual meeting, director elections, and a proposal to increase equity incentive plan shares.
NASDAQ
DEFA14A: Astrana Health, Inc. Sets Date for 2025 Annual Meeting, Outlines Key Proposals for Stockholder Vote
Astrana Health, Inc. announces its 2025 Annual Meeting and details proposals for stockholder voting, including the election of directors, ratification of the company's accounting firm, and approval of executive compensation and an equity incentive plan.
NASDAQ
Astrana Health is holding its 2025 Annual Meeting of Stockholders to elect directors, ratify the appointment of Ernst & Young LLP, approve executive compensation, and approve an amended equity incentive plan.
NASDAQ
DEFA14A: Astrana Health, Inc. Sets Date for 2024 Annual Meeting, Outlines Key Proposals for Stockholder Vote
Astrana Health, Inc. announces its 2024 Annual Meeting to be held on June 12, 2024, with stockholders voting on the election of directors, ratification of the accounting firm, executive compensation, approval of the 2024 Equity Incentive Plan, and an amendment to the company's Restated Certificate of Incorporation.
NASDAQ
DEF 14A: Astrana Health Seeks Stockholder Approval for Officer Exculpation and New Equity Incentive Plan
Astrana Health's proxy statement details proposals for the 2024 annual meeting, including director elections, auditor ratification, executive compensation, a new equity incentive plan, and officer exculpation.